🚨 Breaking down the REGENCY trial 🚨 A Phase 3 RCT evaluating obinutuzumab (Obi) in lupus nephritis (LN). Let's dive into the study design, key findings, and the dosing regimens! 🧵⬇...

Non-­ inferiority trials in cardiology: what clinicians need to know: @Heart_BMJ 🥸 In light of many non-inferiority trials from #ESCCongress, here are 20 facts about superiority...

2016 "Brazilian Expert Works With Local JNF Medical Professionals in St Kitts and Nevis.. the project involves “the use of plasma-based infusion therapies, to a limited number...

What a result for #PREOXI trial at #CCR24! Large, well conducted, highly pragmatic trial leaving little uncertainty of benefit for preoxygenation using NI ventilation on hypoxemi...

Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant...

Over the past 3 years I managed to publish multiple original research projects in top tiered journals using OPEN ACCESS DATA with ZERO funding. Here is how I did it and how you can...

🔥Recently published RCTs in Infectious Diseases 🔥 1️⃣SIMPLIFY @TheLancetInfDis 2️⃣ACCESS @LancetRespirMed 3️⃣Trep-AB @TheLancetInfDis 4️⃣SABATO RCT @TheLancetInfDis 5️⃣PROPHY-VAP...

1/12 TREATMENT OF SEVERE IDA I tweeted a poll yesterday asking how you would treat a 31 yo F with chronic iron deficiency anemia and a Hb 5.9 g/dL. The options included transfusi...

2023 PRACTICE-CHANGING CLINICAL TRIALS #repeat ~~ a thread 🧵 ~~ 👇 https://t.co/FCFC5ffric

2023 PRACTICE-CHANGING CLINICAL TRIALS #recap ~~ a thread 🧵 ~~ 👇

SELECT trial was published today in NEJM. Below, I summarize the trial and the drug in this thread. #MedX #cardioEd #cardioTwitter #MedEd https://t.co/l2lvoyG0L3

Huge news! The #SELECT trial presented at #AHA23 is a game changer. Among adults with CVD and overweight/ #obesity but without diabetes, #semaglutide 2.4mg/wk reduced MACE by 20%,...

🔥Recently published RCTs in Infectious Diseases 🔥 1️⃣@asap_trial @NEJM 2️⃣SOAB RCT @CMIJournal 3️⃣ACORN RCT @JAMA_current 4️⃣ACT HIV RCT @NEJM 5️⃣SAFO RCT @NatureMedicine 6️⃣ERADI...

@CentralParkWMD @TumorBoardTues @MPishvaian @GABOUALFA @SteveMaronMD @MichaelDAngeli2 @MacarullaTeresa @OncBrothers @jhatjhmi1 @KevinCSoaresMD @MDAkhilChawla @FionnualaCrowle @wei_...

Liver cell uptake may be inhibited by silibinin 1. It blocks amatoxin binding to OATPB13 2. It prevented liver injury in a controlled trial in beagles 3. Uncontrolled studies in p...

1/ Excited to share with you our most recent study in @TheLancetOncol assessing the combination of belzutifan + cabozantinib in patients with advanced #RCC previously treated with...

MAIN Trial: Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy - A Randomized Clinical Trial ca. 2023 from @JAMA_current #Nephpearls #NephJC #...

Let's talk about this trial see details below https://t.co/N6AEy98jF5

How do you titrate your PEEP in moderate to severe ARDS Patients?

1. Out of 44,000 clinical trial participants, Pfizer only used data from 170 participants to claim 95% efficacy. https://t.co/6ygrGncRWB

2022 PRACTICE-CHANGING CLINICAL TRIALS #recap ~~ a thread 🧵 ~~ 👇

1) Welcome to our #accredited #tweetorial on clinical trial results and emerging data for HIF-PHIs as therapy for CKD-associated anemia #anemia in #CKD #aCKD. I am Brian Rifkin MD,...

1) Welcome to this new #accredited #tweetorial on “Strategies to Apply Current Clinical Trial Data for SGLT2i to Reduce the Progression of CKD,” authored by our ⭐️tweetorialist Edg...

Our Latest @vkprasadlab Clinical trials enroll X pts per month Which factors speed & slow enrollment? Crossover & 2:1 randomization r touted as enticements-- but do nothing! How c...